An open-label, randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injury.
about
An open-label, randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injury.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
An open-label, randomized and ...... ing drug-induced liver injury.
@ast
An open-label, randomized and ...... ing drug-induced liver injury.
@en
type
label
An open-label, randomized and ...... ing drug-induced liver injury.
@ast
An open-label, randomized and ...... ing drug-induced liver injury.
@en
prefLabel
An open-label, randomized and ...... ing drug-induced liver injury.
@ast
An open-label, randomized and ...... ing drug-induced liver injury.
@en
P2093
P2860
P1476
An open-label, randomized and ...... ting drug-induced liver injury
@en
P2093
Ai-Ping Gao
Bao-Dong Yuan
Cun-Xu Liu
He-Ping Xiao
Li-Hua Huang
Li-Jun Han
Mei-Ying Wu
P2860
P304
P577
2015-03-15T00:00:00Z